Evotec SE
EVT | F
Overview
Corporate Details
- ISIN(s):
- DE0005664809 (+1 more)
- LEI:
- 529900F9KI6OYITO9B12
- Country:
- Germany
- Address:
- Essener Bogen 7, 22419 Hamburg
- Website:
- https://www.evotec.com/en
- Sector:
- Human health and social work activities
- Industry:
- Hospital activities
Description
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-13 07:00 |
Earnings Release
Evotec SE reports H1 2025 results: Strong progress on strategy execution
|
English | 18.4 KB | |
| 2025-08-13 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 613.3 KB | |
| 2025-08-11 16:40 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 59.5 KB | |
| 2025-08-06 09:52 |
Report Publication Announcement
Evotec SE to announce first half-year results 2025 on 13 August 2025
|
English | 11.3 KB | |
| 2025-07-30 07:16 |
M&A Activity
Evotec and Sandoz evolve their strategic partnership and agree on potential sal…
|
English | 14.5 KB | |
| 2025-07-23 15:34 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 56.9 KB | |
| 2025-07-21 11:40 |
Earnings Release
Evotec adjusts revenue guidance and confirms profit guidance anticipating a mor…
|
English | 13.3 KB | |
| 2025-07-15 11:35 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 56.9 KB | |
| 2025-06-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 4.4 KB | |
| 2025-06-25 07:30 |
Regulatory News Service
Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular underst…
|
English | 16.4 KB | |
| 2025-06-19 17:10 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 17.5 KB | |
| 2025-06-13 00:00 |
Governance Information
Declaration of Corporate Management 2024
|
English | 742.8 KB | |
| 2025-06-03 17:00 |
Post-Annual General Meeting Information
Evotec SE: Results of the Annual General Meeting 2025
|
English | 11.3 KB | |
| 2025-05-13 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 260.9 KB | |
| 2025-05-08 07:30 |
Regulatory News Service
Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatmen…
|
English | 12.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-06 | Dohrmann, Dr. Cord | Board | Other | None | 91,363.32 EUR |
| 2024-10-01 | Rouxel, Laetitia | Board | Other | None | 58,396.84 EUR |
| 2024-09-13 | Wojczewski, Dr. Christian | Board | Buy | None | 61,087.50 EUR |
| 2024-09-05 | Dalbiez, Aurélie | Board | Buy | None | 21,202.55 EUR |
| 2024-09-02 | Wojczewski, Dr. Christian | Board | Buy | None | 64,466.00 EUR |
| 2024-08-29 | Löw-Friedrich, Prof. Dr. Iris | Supervisory board | Buy | None | 100,050.00 EUR |
| 2024-08-23 | Wojczewski, Dr. Christian | Board | Buy | None | 113,291.94 EUR |
| 2024-08-22 | Johnstone, Dr. Craig | Board | Buy | None | 16,553.03 EUR |
| 2024-08-19 | Wojczewski, Dr. Christian | Board | Buy | None | 59,766.00 EUR |
| 2024-05-03 | Dohrmann, Dr. Cord | Board | Other | None | 76,220.10 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ADRIANO CARE | Spain | YADR | |
|
AEVIS VICTORIA SA | Switzerland | AEVS | |
|
Ambea | Sweden | AMBEA | |
|
ANGLING DIRECT PLC | United Kingdom | ANG | |
|
ANGLO ASIAN MINING PLC | Azerbaijan | AAZ | |
|
Athens Medical C.S.A. | Greece | IATR | |
|
Attendo | Sweden | ATT | |
|
Bastide Le Confort Médical | France | BLC | |
|
Biocartis Group NV | Belgium | BCART | |
|
Bio-Gate AG | Germany | BIG1 |